About Bifidobacterium
Bifidobacterium is a Healthcare company based in Panchkula (India) founded in 2022. It manufactures enzymes and probiotics for health, food, and chemical sectors. It operates on a B2B model. Its Indian entity Fido Pharma Private Limited reported revenue of ₹20.59 Cr. Bifidobacterium offers products and services including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements. Its focus areas include Food and Agriculture Tech, Nutraceuticals, Dietary Supplements and Biopharmaceutical.
Company details
Fido Pharma Private Limited produces enzyme solutions and probiotics for applications in biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. They focus on high-quality manufacturing and supply to support health benefits like digestive health and immunity. Based in Panchkula, India, with additional sites in Hyderabad, they serve global customers through B2B channels, emphasizing innovation in health supplements.
- Headquarters Panchkula, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bifidobacteriumspecies.com
- Legal Name Fido Pharma Private Limited
- Date of Incorporation 04 Mar, 2020
- Jurisdiction Panchkula, Haryana, India
- Annual Revenue₹20.59 Cr
FY 2024 · +190% YoY
- Net Profit₹4.07 Cr
FY 2024 · 20% margin
- EBITDA₹4.89 Cr
FY 2024 · 24% margin
Associated legal entities of Bifidobacterium
Bifidobacterium operates through Fido Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fido Pharma Private Limited CIN U24230HR2020PTC085725 | Active | 04 Mar 2020 | Panchkula, Haryana | ₹20.6 Cr | 3 | View details |
Products & Services of Bifidobacterium
Bifidobacterium offers a comprehensive portfolio of products and services, including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.
Enzymes for industrial applications in health and food processing.
Probiotics to enhance digestive health and immune function.
Blended probiotics for targeted health benefits.
Nutraceuticals supporting overall wellness and nutrition.
Supplements derived from probiotics for daily health maintenance.
Board of directors of Fido Pharma Private Limited (Bifidobacterium)
Fido Pharma Private Limited is the primary company behind Bifidobacterium. The board of Fido Pharma Private Limited currently have 3 directors; the longest-serving is Tejal Ashok Vispute, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejal Ashok Vispute DIN 08717158 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Parbhat Singh DIN 08717156 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Ritu Raj Singh DIN 10186291 | Director | 30 May 2023 | 3 yrs 4 mo | Fido Pharma Private Limited |
Financials of Bifidobacterium
Figures of Fido Pharma Private Limited, the primary company behind Bifidobacterium, for FY 2024. Revenue was ₹20.59 Cr (+190% year on year). Net profit was ₹4.07 Cr (20% margin). EBITDA was ₹4.89 Cr (24% margin). Revenue has grown at a compounded annual rate of +114% over three years.
- ₹20.59 CrRevenue · FY 2024 · +190% YoY
- ₹4.07 CrNet profit · 20% margin
- ₹4.89 CrEBITDA · 24% margin
- ₹50 LakhPaid-up capital
- +114%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Fido Pharma Private Limited are on its company page.
Detailed financial statements for Bifidobacterium
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bifidobacterium
Bifidobacterium was founded in 2022.
Bifidobacterium is headquartered in Panchkula, India. It is registered at Panchkula, Haryana, India.
The primary company behind Bifidobacterium, Fido Pharma Private Limited, reported revenue of ₹20.59 Cr for FY 2024, up 190% year on year.
Fido Pharma Private Limited produces enzyme solutions and probiotics for applications in biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. They focus on high-quality manufacturing and supply to support health benefits like digestive health and immunity. Based in Panchkula, India, with additional sites in Hyderabad, they serve global customers through B2B channels, emphasizing innovation in health supplements.
Bifidobacterium offers Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.
Bifidobacterium operates through Fido Pharma Private Limited.
The legal entities of Bifidobacterium currently have 3 directors, including Tejal Ashok Vispute, Parbhat Singh, Ritu Raj Singh.